NYU Langone — New York, New York

NYU Langone is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

NYU Langone has participated in 81 clinical trials with 39 currently active.

Therapeutic areas: Mental Health Issue, Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer, Esophageal Adenocarcinoma.

Sponsors: NYU Langone Health, Taiho Oncology, Inc., Fox Chase Cancer Center.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NYU Langone?

NYU Langone has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NYU Langone conducted?

NYU Langone has 81 clinical trials on record, with 39 currently active. Their work covers Mental Health Issue, Locally Advanced Unresectable or Metastatic Solid Tumors Including Esophageal Cancer, Esophageal Adenocarcinoma.

Is NYU Langone accredited by Crixeo Health?

NYU Langone has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NYU Langone?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.